71773-050 : Xerava 50 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 71773-050
Labeler: Tetraphase Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Xerava
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA211109
Rev. Date: 


NDC Package Codes:

  • 71773-050-05: 1 VIAL, GLASS IN 1 CARTON (71773‑050‑05) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, GLASS
  • 71773-050-12: 12 VIAL, GLASS IN 1 CARTON (71773‑050‑12) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, GLASS

Active Ingredients:

  • Eravacycline Dihydrochloride

Dosage Strength:

  • 50 mg

Pharmaceutical Classes:

  • Tetracycline-class Antibacterial [EPC]
  • Tetracyclines [CS]

Related Products:

Based on records with the same trade name.
  • 71773-100 Xerava 100 mg Intravenous Injection, Powder, Lyophilized, for Solution by Tetraphase Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71773-050 QR Code

< Prev: 71772-486Next: 71773-100 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.